BridgeBio shares surge 25% on FDA approval of Attruby

Nov 25, 2024 - 11:30

BridgeBio shares surge 25% on FDA approval of Attruby

AMAZON.CA DEALS

AMAZON.CA DEALS

Previous Article

Cassava shares plunge 85% as Alzheimer's study fails to meet endpoints

Quikrete to take Summit Materials private in deal valued at $11.5 billion

SHOP AMAZON.CA

SHOP AMAZON.CA

Related Posts

Goldman Sachs shares gain for fourth straight day amids...

Oct 9, 2023

Indians vote in huge election dominated by jobs, Hindu ...

Apr 19, 2024

Australia stocks higher at close of trade; S&P/ASX 200 ...

Nov 30, 2023

China Evergrande's EV arm units to enter bankruptcy, re...

Aug 4, 2024

Senior Aerospace secures $12m deal with UAE's Strata fo...

Dec 5, 2023

Boeing workers to go on strike as union rejects labor d...

Sep 13, 2024

As an Amazon Partner, I may be compensated if you make a purchase - at no additional cost to you.

TODAY'S DEALS

As an Amazon Partner, I may be compensated if you make a purchase - at no additional cost to you.

SHOP AMAZON.CA